Growth Potential Elge, Inc. operates within the pharmaceutical manufacturing sector with an annual revenue estimated between $10 million and $25 million, indicating room for expansion and scale opportunities in private label pharmaceutical production for national brands.

Manufacturing Expertise Specializing in a diverse range of products including OTC and DEA-controlled substances, Elge offers comprehensive manufacturing capabilities that can meet varied client needs, making it an attractive partner for companies seeking reliable production of complex pharmaceutical formulations.

Technology Adoption Utilizing advanced technology platforms such as Telerik Sitefinity, ASP.NET, and Nginx, Elge demonstrates a commitment to modern, efficient management and production processes, ensuring high-quality output that could appeal to clients prioritizing technological sophistication.

Market Niche With a focus on private label manufacturing and a broad product portfolio, Elge can serve niche pharmaceutical markets and smaller brands looking for tailored manufacturing solutions, opening opportunities for collaborations with emerging or generic pharmaceutical companies.

Leadership & Values Led by President Larry Gremminger, a seasoned pharmacist with industry memberships, Elge emphasizes integrity, honesty, and loyalty, which can be leveraged to build trust with clients seeking dependable manufacturing partners with strong ethical standards.